| Autor: |
Franco, Claudinéia Conationi da Silva, Miranda, Rosiane aparecida, de Oliveira, Júlio Cezar, Barella, Luiz Felipe, agostinho, aryane Rodrigues, Prates, Kelly Valério, Malta, ananda, Trombini, amanda Bianchi, Torrezan, Rosana, Gravena, Clarice, Tófolo, Laize P., de Sant'anna, Juliane Rocha, de Castro Prado, Marialba avezum alves, de Souza, Camila Oliveira, de Souza, Helenir Medri, Beraldi, Evandro José, Mathias, Paulo Cezar de Freitas |
| Předmět: |
|
| Zdroj: |
Cellular Physiology & Biochemistry (Karger AG); Dec2014, Vol. 34 Issue 6, p1920-1932, 13p |
| Abstrakt: |
Background/Aims: The objective of the current work was to test the effect of metformin on the tumor growth in rats with metabolic syndrome. Methods: We obtained pre-diabetic hyperinsulinemic rats by neonatal treatment with monosodium L-glutamate (MSG), which were chronically treated every day, from weaning to 100 day old, with dose of metformin (250 mg/kg body weight). After the end of metformin treatment, the control and MSG rats, treated or untreated with metformin, were grafted with Walker 256 carcinoma cells. Tumor weight was evaluated 14 days after cancer cell inoculation. The blood insulin, glucose levels and glucose-induced insulin secretion were evaluated. Results: Chronic metformin treatment improved the glycemic homeostasis in pre-diabetic MSG-rats, glucose intolerance, tissue insulin resistance, hyperinsulinemia and decreased the fat tissue accretion. Meanwhile, the metformin treatment did not interfere with the glucose insulinotropic effect on isolated pancreatic islets. Chronic treatment with metformin was able to decrease the Walker 256 tumor weight by 37% in control and MSG rats. The data demonstrated that the anticancer effect of metformin is not related to its role in correcting metabolism imbalances, such as hyperinsulinemia. However, in morphological assay to apoptosis, metformin treatment increased programmed cell death. Conclusion: Metformin may have a direct effect on cancer growth, and it may programs the rat organism to attenuate the growth of Walker 256 carcinoma. © 2015 S. Karger AG, Basel [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
